Global Live Cell Imaging Market Overview
Live Cell Imaging Market Size was valued at USD 5.12 Billion in 2023. The Global Live Cell Imaging industry is projected to grow from USD 6.78 Billion in 2024 to USD 8.70 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 10.23% during the forecast period (2024 - 2032). Increasing prevalence of chronic diseases and growing government funding in cell-based research. These are just a few of the market drivers that are driving the market.
June 2023: Nanolive has announced the launch of a new platform that instantly delivers live cell imaging without any stains or labels, the 3D Cell Explorer 96focus. Through this platform, their aim is to enable users to carry out virtually limitless high-content analysis on label-free live cells. Using AI-driven digital assays and streamlined workflow, the 3D Cell Explorer 96focus reduces the complexities in the imaging process, thus providing cost-effective and reliable means required for conducting cell imaging experiments.
February 2023: Nikon has just introduced its Nikon Spatial Array Confocal (NSPARC) detector for AX systems which offers high-resolution pictures of life tissues and causes minimum phototoxic effects.
In January 2023, Bruker Corporation completed the deal to purchase ACQUIFER Imaging GmbH, an innovator in big-data management solutions for bioimaging and high-content microscopy. This acquisition adds high-performance on-premise processing, secure storage, and networking technology, which complements Bruker’s advanced fluorescence microscopy imaging products, such as light-sheet and super-resolution microscopy products generating high information content.
For example, Axion BioSystems, one of the leading life sciences tools companies for advanced live-cell assay systems, reported about the acquisition of CytoSMART Technologies, which is a young start-up company developing kinetic live-cell imaging analysis in March 2022.
Furthermore, TGen collaborated with Deepcell in February 2022 to employ artificial intelligence-based technology to classify diseased cells. In particular, Deepcell has created AI-powered technology that changes cell morphology into a quantitative and high throughput marker for use in research while complementing existing molecular workflows or even as a stand-alone method.
Also, Zeiss group launched ZEISS Visioner1, a digital microscope made for live-cell imaging with an all-in-one focus through its Micro-mirror Array Lens System (MALS) that facilitates real-time images by shifting between different focal planes in January 2021. The aim behind this move was to simplify the imaging process and enhance high throughput.
In June 2020, InnoME, Gmbh and Etaluma, Inc. entered a partnership to bring entry-level incubator cell imaging to the Americas.
Sartorius also launched its newest live-cell analysis product line called Incucyte SX5 Live-Cell Analysis System in May 2020, which is aimed at the biopharmaceutical industry.
Live Cell Imaging Market Trends
- Growing Target Patient Population and an increase in funding for advances and newer cell therapy will boost market growth
A crucial tool in the study of cancer biology is live cell imaging. Live cell imaging is crucial for a deeper comprehension of the function and disease processes, even though high-resolution imaging is necessary for analyzing genetic and cell signaling alterations in the underlying malignancy. Every year, almost 400,000 kids are diagnosed with cancer. Communicable illnesses impact both developed and developing nations. Most emerging nations are exposed due to several variables, including demographic, socioeconomic, and geographic circumstances. Thus, the market for live cell imaging is driven by the rising mortality toll and the prevalence of chronic diseases.
Artificial intelligence's (A.I.) place in biological sciences is growing quickly and has a lot of promise for microscopy. The ability of microscopy to confirm or refute scientific ideas in the past was scale-restricted, and the time required to measure, capture, and analyze many pictures were frequently prohibitive. Recently, A.I. has quickly impacted several scientific disciplines, including microscopy. Self-learning microscopy powered by A.I. can deliver high throughput image analysis quicker and easier. Better long-term viewing of unlabeled living cells is made possible by more recent A.I. technologies. . Thus, this factor drives the market CAGR.
The need for regenerative medicine has expanded in industrialized nations, and recent years have seen a sharp surge in spending on cell and gene therapy. Developers of cell and gene therapies are receiving financing from both the public and private sectors. Recent years have seen a significant increase in the funding of biotech start-ups and research institutions that work on developing new cell and gene therapy products for several public and commercial entities. The Alliance for Regenerative Medicines reports that funding for cell and gene therapy increased by 164% in 2022 compared to 2020
Live cell imaging results from scientific curiosity and imaging and labeling technology advancements. Live cell imaging has many additional applications for scientists when different technical breakthroughs and biological interests are combined. An extensive range of nucleic acids, proteins, glycans, lipids, ions, metabolites, and other targets may now be tagged, especially thanks to significant advancements in probe creation. Several recent developments in microscopic Technology use software that improves quantitative image analysis of label-free pictures. Thus, this aspect will accelerate the Live Cell Imaging market revenue globally.
Live Cell Imaging Market Segment Insights
Live Cell Imaging Products Insights
Based on products, the Live Cell Imaging Market segmentation includes Equipment, Consumables, and Software. The consumables segment held the majority share in 2022 in the Live Cell Imaging Market data. During the projection period, the need for frequent purchases of consumables is anticipated to be a major factor in the market's expansion.
Figure 1: Live Cell Imaging Market, by Products, 2023 & 2032 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Live Cell Imaging End-user Insights
Based on End-user, the Live Cell Imaging Market segmentation includes pharmaceutical companies, Hospitals and Biotechnological companies. The hospitals segment dominated the market growth in 2022 and is projected to be the faster-growing segment during the forecast period, 2022-2030. The significant market share of this sector can be ascribed to the expansion of R&D efforts and the patent expiration of several blockbuster medications.
Live Cell Imaging Technology Insights
Based on Technology, the Live Cell Imaging Market data includes Fluorescence Recovery After Photobleaching (FRAP), Total Internal Reflection Fluorescence Microscopy (TRIF), High-content analysis, and Fluorescence in situ hybridization. The fluorescence recovery after the photobleaching segment dominated the Live Cell Imaging market revenue in 2022 and is projected to be the faster-growing segment during the forecast period, 2022-2030, due to its several benefits in determining the protein levels' spatial closeness. Additionally, the increased use of genetic peptides has recently made this technique more well-known.
Live Cell Imaging Application Insights
Based on application, the Live Cell Imaging Market data includes Drug Discovery, Cell Biology, and Others. The cell imaging segment dominated the Live Cell Imaging market revenue in 2022 and is projected to be the faster-growing segment during the forecast period 2022-2030. Aside from this, other cutting-edge technologies that heavily influence the process include sophisticated lighting systems and filtration approaches.
Live Cell Imaging Regional Insights
By region, the study provides market insights into North America, Europe, Asia-Pacific and the Rest of the World. The North America Live Cell Imaging market accounted for USD 2.15 billion in 2022 with a share of around 45.80% and is expected to exhibit a significant CAGR growth during the study period. The presence of a bigger patient pool and an expanding senior population is said to account for the majority of the share. The main forces in this area are the significant funding and investment available for live-cell imaging research. Due to factors including an increase in chronic illnesses and the amount of research and development (R&D) programs in the nation, the United States now owns the greatest market share in the North American area. In the United States, around 34,800 new HIV infections were reported in 2020, according to the most recent estimates from the Centers for Disease Control and Prevention. According to the same source, 13% of Americans with HIV are unaware of their condition and urgently want a diagnosis.
Further, the major countries studied in the market report are The U.S., Canada, Germany, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.
Figure 2: LIVE CELL IMAGING MARKET SHARE BY REGION 2023 (%)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
The second-largest share in the world is held by Europe Live Cell Imaging market, which may be attributed to several factors, including a rising patient population in need of novel therapies like stem cell therapy and gene therapy, an increase in the number of drugs approved for precision medicine, government financing for research-based activities, quick developments in live cell imaging, and several others. Moreover, the U.K. Live Cell Imaging market held the largest market share, and the Germany Live Cell Imaging market was the fastest-growing market in the region.
The Asia Pacific Live Cell Imaging market region has the significant anticipated growth rate. The government-sponsored research on stem cell therapy, the growing importance of regenerative medicine research, the expansion of preclinical and clinical research in China, the favorable changes in foreign direct investment (FDI) regulations in the pharmaceutical industry in India, and the expansion of the pharmaceutical and biopharmaceutical sectors in South Korea are the main causes of this region's high growth rate. Further, the China Live Cell Imaging market held the largest market share, and the India Live Cell Imaging market was the fastest-growing market in the region.
Live Cell Imaging Key Market Players & Competitive Insights
Major industry companies are investing a lot of money in R&D to expand their product offerings, which will spur further market expansion for the Live Cell Imaging industry. With significant industry changes, including new product launches, mergers and acquisitions, contractual agreements, higher investments, and collaboration with other organizations, market developments are also undertaking various strategic activities to expand their global presence. To grow and remain in a market that is becoming more and more competitive, Live Cell Imaging industry competitors must provide affordable products.
Manufacturing locally to cut operational costs is one of the producers' main business methods in the global Live Cell Imaging industry to benefit customers and increase the market sector. The Live Cell Imaging industry has recently given medicine some of the most important advantages. The Live Cell Imaging market major player such as Carl Zeiss AG (Germany), Leica Microsystems (Germany), Olympus Corporation (Japan), Sigma-Aldrich Corporation (U.S.), Nikon Corporation (Japan), Molecular Devices, LCC (U.S.), PerkinElmer, Inc. (U.S.), G.E. Healthcare (U.K.), Becton, Dickinson and Company (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Danaher Corporation (U.S.) and BioTek Instruments (U.S.).
Time-lapse microscopy is used to analyze live cells in live-cell imaging. Scientists can get a deeper knowledge of biological functions by investigating cellular dynamics. The Lux3 FL Duo Kit and Multi Lux3 FL were two new fluorescence live-cell imaging systems introduced in June 2021 by CytoSMART Technologies BV, a prominent provider of intelligent solutions for live-cell imaging in cell culture facilities. The objective of this launch is to compare cell cultures side by side.
A German firm that manufactures microscopes is called Leica Microsystems GmbH. It produces optical microscopes, tools for preparing microscopic specimens, and associated goods. Leica Microsystems GmbH, a well-known German manufacturer of microscopes, and the European Molecular Biology Laboratory reached an agreement in December 2019. (EMBL). This partnership will develop new imaging technologies that are useful in life science.
Key Companies in the Live Cell Imaging market include
- Leica Microsystems (Germany)
- Sigma-Aldrich Corporation (U.S.)
- Nikon Corporation (Japan)
- Becton Dickinson and Company (U.S.)
- Thermo Fisher Scientific Inc. (U.S.)
- Danaher Corporation (U.S.)
- BioTek Instruments (U.S.)
Live Cell Imaging Industry Developments
-
September 2021: PHC Holdings Corporation's subsidiary PHC Corporation, a market leader in the development, design, and production of lab equipment, has announced a cooperation with SCREEN Holdings Co. Ltd. The alliance aims to market live-cell imaging instruments from the SCREEN Cell3iMager line in North America.
-
April 2019: Nikon Corporation has unveiled two new silicone immersion objective lenses: the CFI Plan Apochromat Lambda S 40XC Sil and the CFI Plan Apochromat Lambda S 25XC Sil. The most recent microscopes to be released are confocal laser microscopy systems and Ti2 inverted research microscopes.
-
July 2018: Bruker Corporation, a producer of scientific equipment, has purchased JPK Instruments AG, a prominent maker of nano-analytical instruments. The purpose of this acquisition is to improve Bruker Corporation's microscopy capabilities.
Live Cell Imaging Market Segmentation
Live Cell Imaging Product Outlook
Live Cell Imaging Technology Outlook
- Fluorescence recovery after photobleaching (FRAP)
- Total Internal Reflection Fluorescence Microscopy (TRIF)
- Fluorescence in situ hybridization
Live Cell Imaging Application Outlook
Live Cell Imaging End-User Outlook
- Biotechnological companies
Live Cell Imaging Regional Outlook
| Report Attribute/Metric |
Details |
| Market Size 2023 |
USD 5.12 billion |
| Market Size 2024 |
USD 6.78 billion |
| Market Size 2032 |
USD 8.70 billion |
| Compound Annual Growth Rate (CAGR) |
10.23% (2024-2032) |
| Base Year |
2023 |
| Market Forecast Period |
202-2032 |
| Historical Data |
2018 - 2021 |
| Market Forecast Units |
Value (USD Billion) |
| Report Coverage |
Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends |
| Segments Covered |
Variety, Form, Distribution Channel and Region |
| Geographies Covered |
North America, Europe, Asia Pacific, and the Rest of the World |
| Countries Covered |
Carl Zeiss AG (Germany), Leica Microsystems (Germany), Olympus Corporation (Japan), Sigma-Aldrich Corporation (U.S.), Nikon Corporation (Japan), Molecular Devices, LCC (U.S.), PerkinElmer, Inc. (U.S.), G.E. Healthcare (U.K.), Becton, Dickinson and Company (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Danaher Corporation (U.S.) and BioTek Instruments (U.S.) |
| Key Companies Profiled |
Nestle, JM Smucker Company, The Kraft Heinz Company and Starbucks Live Cell Imaging Company |
| Key Market Opportunities |
Use of high-content screening methods in cell biology and drug discovery |
| Key Market Dynamics |
Increasing prevalence of chronic diseases Growing government funding in cell-based research |
Frequently Asked Questions (FAQ) :
The Live Cell Imaging Market size was valued at USD 5.12 Billion in 2023.
The Live Cell Imaging Market is projected to grow at a CAGR of 10.23% during the forecast period, 2024-2032.
North America had the largest share in the global Live Cell Imaging market
The key players in the market are Carl Zeiss AG (Germany), Leica Microsystems (Germany), Olympus Corporation (Japan), Sigma-Aldrich Corporation (U.S.), Nikon Corporation (Japan), Molecular Devices, LCC (U.S.), PerkinElmer, Inc. (U.S.), G.E. Healthcare (U.K.), Becton, Dickinson and Company (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Danaher Corporation (U.S.) and BioTek Instruments (U.S.) Company.
The consumable category dominated the Live Cell Imaging market in 2022.
The Pharmaceutical companies had the largest share in the global Live Cell Imaging market.
